KI, OUH, Forskningsenhed for OPEN - Open Patient data Explorative Network (Odense)

Medicin og biovidenskab

1. Denmark 100%
2. Cohort Studies 85%
3. Guinea-Bissau 76%
4. Vaccination 60%
5. Randomized Controlled Trials 59%
6. Child 50%
7. Population 46%
8. Mortality 45%
9. Osteoporosis 38%
10. Registries 37%
11. Systematic Reviews 35%
12. Twins 35%
13. Vaccines 33%
14. Measles Vaccine 32%
15. Confidence Intervals 31%
16. Therapeutics 28%
17. Health 28%
18. Parturition 26%
19. Diphosphonates 26%
20. Hip Fractures 25%
21. Quality of Life 24%
22. Bone and Bones 24%
23. Prospective Studies 24%
24. Twin Studies 24%
25. Bone Density 23%
26. Poliomyelitis 23%
27. Bacillus 22%
28. Pregnancy 22%
29. Delivery of Health Care 22%
30. Measles 22%
31. Meta-Analysis 22%
32. Mothers 21%
33. Osteoporotic Fractures 20%
34. Incidence 19%
35. Cross-Sectional Studies 19%
36. Comorbidity 19%
37. Vitamin A 18%
38. Bone Remodeling 17%
39. Type 2 Diabetes Mellitus 17%
40. BCG Vaccine 17%
41. Odds Ratio 17%
42. Mycobacterium bovis 17%
43. Observational Studies 17%
44. Placebos 16%
45. Survival 16%
46. Diabetic Retinopathy 16%
47. Neoplasms 15%
48. Biomarkers 15%
49. Type 1 Diabetes Mellitus 15%
50. Patient Reported Outcome Measures 15%
51. Haemophilus influenzae type b 14%
52. Vitamin D 14%
53. Morbidity 14%
54. Serum 14%
55. Prescriptions 14%
56. Whooping Cough 14%
57. Immunity 14%
58. Diphtheria 14%
59. Rheumatoid Arthritis 13%
60. Child Mortality 13%
61. Lung Neoplasms 13%
62. Tetanus 13%
63. Exercise 13%
64. Alendronate 12%
65. Databases 12%
66. Infections 12%
67. Heterologous Immunity 12%
68. Mental Health 12%
69. Alcohols 12%
70. Pain 11%
71. Norway 11%
72. Polycystic Ovary Syndrome 11%
73. Diphtheria-Tetanus-Pertussis Vaccine 11%
74. Income 11%
75. Interviews 11%
76. Body Mass Index 11%
77. Pandemics 11%
78. Safety 11%
79. Infant Mortality 11%
80. Referral and Consultation 10%
81. Alcoholism 10%
82. Smoking 10%
83. Cardiovascular Diseases 10%
84. Dizygotic Twins 10%
85. Cytokines 10%
86. Asthma 10%
87. Genes 10%
88. Uterine Cervical Neoplasms 10%
89. Guidelines 10%
90. Pregnant Women 9%
91. Pharmaceutical Preparations 9%
92. Sweden 9%
93. Outpatients 9%
94. Multicenter Studies 9%
95. Breast Neoplasms 9%
96. Depression 9%
97. Hospitalization 9%
98. Coronavirus 9%
99. Photon Absorptiometry 9%
100. Logistic Models 9%